OTC Drugs & Dietary Supplements Market Report 2020-2030
Forecasts to 2030 and other analyses reveal the commercial prospects
- In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
- You find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
By Product Type
- Branded Drugs
- Generic Drugs
- Cough
- Cold and Flu Drugs
- Analgesics
- Dermatological
- Vitamins and Minerals
- Weight Loss/Diet Product
- Gastrointestinal Drugs
- Pharmacies/Drugstores
- Supermarkets/Hypermarkets
- Convenience Stores
- Online Drugstores
- Health Food Stores
- Tablets
- Hard Capsules
- Powders
- Ointments
- Soft Capsules
- Liquids
- Other Dosage Forms
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
- Turkey
- Saudi Arabia
- South Africa
- UAE
- Qatar
- Rest of Middle East and Africa
Leading companies and the potential for market growth
Overall world revenue for Global OTC Drugs and Dietary Supplements Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
Leading companies featured in this report include:
- Abbott Laboratories
- ASKA Pharmaceutical Co., Ltd.
- Fresenius SE & Co KGaA
- H. Lundbeck A/S
- Lupin Pharmaceuticals
- Mylan NV
- Nippon Chemiphar Co., Ltd.
- Novartis AG
- Pfizer Inc.
- Roche Holding
- Sanofi SA
- Sun Pharmaceutical Industries Ltd
- Taisho Pharmaceutical Holdings Co Ltd
- Teva Pharmaceuticals
In summary, our 700+ page report provides you with the following knowledge:
- Revenue forecasts to 2030 for Global OTC Drugs and Dietary Supplements Market, with forecasts for Product Type, Category, Dosage Form, Distribution Channel, Application, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
- Revenue forecasts to 2030 for 5 regional and 20 key national markets – See forecasts for the Global OTC Drugs and Dietary Supplements market in North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the major companies involved in the Global OTC Drugs and Dietary Supplements Market. Some of the companies profiled in this report include Taisho Pharmaceutical Holdings Co., Ltd., Nippon Chemiphar Co., Ltd., H Lundbeck A/S, ASKA Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Limited, Novartis AG, Pfizer Inc., Mylan N.V., Abbott Laboratories, Fresenius SE & Co KGaA, Sun Pharmaceutical Industries Limited, Sanofi, Roche Holding AG (Roche), Lupin Limited.
The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.
- 1. Report Overview
- 1.1 Global OTC Drugs & Dietary Supplements Market Overview
- 1.2 Market Definitions
- 1.2.1 OTC Drugs
- 1.2.2 Dietary Supplements (VMS)
- 1.3 Why You Should Read This Report
- 1.4 How This Report Delivers
- 1.5 Key Questions Answered by This Analytical Report Include:
- 1.6 Who is This Report For?
- 1.7 Methodology
- 1.7.1 Primary Research
- 1.7.2 Secondary Research
- 1.8 COIVD-19 Impact Recovery Pattern Analysis
- 1.8.1 V-Shaped Recovery
- 1.8.2 U-Shaped Recovery
- 1.8.3 W-Shaped Recovery
- 1.8.4 L-Shaped Recovery
- 1.9 Market Segmentation
- 1.10 Frequently Asked Questions (FAQ)
- 1.11 Associated Visiongain Reports
- 2. Executive Summary
- 2.1 Segmental Insights
- 2.2 COIVD Impact on OTC Product Sales
- 3. Introduction to OTC Pharmaceuticals
- 3.1 What Are OTC Pharmaceuticals?
- 3.2 Classification of OTC Pharmaceuticals
- 3.3 What are the Requirements for an OTC Pharmaceutical Drug?
- 3.4 OTC Switching
- 3.4.1 How Is a Drug Switched from Prescription to OTC?
- 3.4.2 Manufacturing and Distribution of OTC Pharmaceuticals
- 3.5 Regulation of OTC Pharmaceuticals
- 3.5.1 Regulation of OTC Pharmaceuticals in the US
- 3.5.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs
- 3.5.3 Regulations of OTC Pharmaceuticals in Europe
- 3.5.4 Regulation of OTC Pharmaceuticals in China
- 3.5.5 Regulation of OTC Pharmaceuticals in Other Countries
- 4. Market Dynamics
- 4.1 COVID-19 Impact on Pharmaceutical Manufacturing Market
- 4.2 Market Drivers for OTC Drugs
- 4.2.1 Prevalence Of Self-Care
- 4.2.2 Burden On Public Health System
- 4.2.3 Retain Market Leadership
- 4.2.4 Effective Distribution Networks Due to Expansion of Retail Pharmacy and Alternative Distributors
- 4.2.5 Manufacturers Can Reap OTC Sales Benefits
- 4.2.6 Third Party Payers: Reducing the Cost Burden
- 4.2.7 Healthcare Systems: Pushing the Cost to the Consumer
- 4.2.8 Many Pharmaceutical Companies Have a Strong Potential OTC Portfolio
- 4.2.9 Regulators are Encouraging OTC Approvals
- 4.2.10 Deterring the Consumption of Counterfeit Drugs
- 4.2.11 Cultural Changes Will Support Self-Medication with OTC Medicines
- 4.3 Market Drivers for Dietary Supplement
- 4.3.1 Increase Education Campaigns on the Importance Of Dietary Supplement Quality
- 4.3.2 Increasing Demand from Consumer Side
- 4.3.3 Presence of a Large Number of Manufacturers in the Market
- 4.4 Market Growth Restraining Factors
- 4.4.1 Pharma Companies Remain Focused on Prescription Drugs
- 4.4.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs
- 4.4.3 OTC Products are Vulnerable to Price Controls by Governments
- 4.4.4 Downward Cost Pressures of OTC Drugs
- 4.5 Opportunities in the Global Market
- 4.5.1 Demographic and Economic Changes Will Create Growth Opportunities
- 4.5.2 New OTC Switch Categories
- 4.5.3 Strong Growth in Emerging Markets
- 4.5.4 New Healthcare Technologies May enable OTC Approvals
- 4.5.5 Opportunities to Drive Sales via Social Media and Online Marketing
- 4.5.6 Self-Medication can Reduce the Under Treatment of Disease
- 4.6 Challenges in the Global Market
- 4.6.1 Competition from Private-Label Brands Will Reduce Profitability
- 4.6.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products
- 4.6.3 Resistance to OTC Switching from Some Groups in Certain Countries
- 4.7 Porter’s Five Forces Analysis
- 4.7.1 Rivalry Among Competitors [High]
- 4.7.2 Threat of New Entrants [Medium]
- 4.7.3 Power of Suppliers [Low]
- 4.7.4 Power of Buyers [Medium]
- 4.7.5 Threats of Substitutes [Medium]
- 4.8 Rules and Regulations For OTC Drugs And Dietary Supplements
- 4.8.1 Regulations for OTC Drugs
- 4.8.2 Regulations For Dietary Supplements
- 4.9 Roadmap for Global Market
- 4.9.1 The Practice Of Buying OTC Drugs
- 4.9.2 Role Of Pharmacy In OTC Drugs
- 4.9.3 Regulatory Influence On OTC Drug Market
- 4.10 SWOT Analysis of OTC Drug And Dietary Supplement Industry
- 4.10.1 Strengths
- 4.10.1.1 OTC Medication Awareness
- 4.10.1.2 Drugs Regulations
- 4.10.1.3 Clinical Evidences
- 4.10.2 Weaknesses
- 4.10.2.1. Self-Medication could be Risky
- 4.10.2.2. Some OTC Drugs Carry Side Effects
- 4.10.2.3. Price of OTC Drugs Are Pharmacy Driven
- 4.10.3 Opportunities
- 4.10.3.1. OTC Drug Approvals for new diseases
- 4.10.3.2. Shift to Emerging Markets
- 4.10.3.3. Tie-ups in Third-Party Manufacturing
- 4.10.4 Threats
- 4.10.4.1 Low Awareness of Drugs
- 4.10.4.2 Increase in herbal remedies, probiotics and other alternatives for self-care
- 4.10.4.3 Market saturation with me-too products
- 5. Global OTC Drugs & Dietary Supplements Market Analysis
- 5.1 Well-Developed Markets
- 5.2 Developing Markets
- 5.3 Under-Developed Markets
- 5.2 Market Analysis in Terms of Value
- 5.2.1 Market Analysis in Terms of Value (Before COVID-19)
- 5.2.2 Market Analysis in Terms of Value (V-shaped)
- 5.2.1 Market Analysis in Terms of Value (W-shaped)
- 5.2.1 Market Analysis in Terms of Value (U-shaped)
- 5.2.1 Market Analysis in Terms of Value (L-shaped)
- 5.3 Market Analysis by Region
- 5.3.1 North America to Lead the Global Market
- 5.3.2 Market Analysis in Terms of Value (Before COVID-19)
- 5.3.3 Market Analysis in Terms of Value (V-shaped)
- 5.3.4 Market Analysis in Terms of Value (W-shaped)
- 5.3.5 Market Analysis in Terms of Value (U-shaped)
- 5.3.6 Market Analysis in Terms of Value (L-shaped)
- 5.4 Market Analysis by Product Category
- 5.4.1 Cough, Cold and Flu Drugs Segment will Dominate the Market During Forecast Period
- 5.4.2 Market Analysis in Terms of Value (Before COVID-19)
- 5.4.3 Market Analysis in Terms of Value (V-shaped)
- 5.4.4 Market Analysis in Terms of Value (W-shaped)
- 5.4.5 Market Analysis in Terms of Value (U-shaped)
- 5.4.6 Market Analysis in Terms of Value (L-shaped)
- 5.5 Market Analysis by Product Type
- 5.5.1 Branded Drugs Are Preferred Over Generic Drugs
- 5.5.2 Market Analysis in Terms of Value (Before COVID-19)
- 5.5.3 Market Analysis in Terms of Value (V-shaped)
- 5.5.4 Market Analysis in Terms of Value (W-shaped)
- 5.5.5 Market Analysis in Terms of Value (U-shaped)
- 5.5.6 Market Analysis in Terms of Value (L-shaped)
- 5.6 Market Analysis by Dosage Form
- 5.6.1. Consumers Prefer to Take Drugs in Tablet Form
- 5.6.2 Market Analysis in Terms of Value (Before COVID-19)
- 5.6.3 Market Analysis in Terms of Value (V-shaped)
- 5.6.4 Market Analysis in Terms of Value (W-shaped)
- 5.6.5 Market Analysis in Terms of Value (U-shaped)
- 5.6.6 Market Analysis in Terms of Value (L-shaped)
- 5.7 Market Analysis by Distribution Channel
- 5.7.1. Pharmacies/Drugstores Are Still the Sales Centres for OTC Drugs
- 5.7.2 Market Analysis in Terms of Value (Before COVID-19)
- 5.7.3 Market Analysis in Terms of Value (V-shaped)
- 5.7.4 Market Analysis in Terms of Value (W-shaped)
- 5.7.5 Market Analysis in Terms of Value (U-shaped)
- 5.7.6 Market Analysis in Terms of Value (L-shaped)
- 6. Market Breakdown by Product Category
- 6.1 Cough, Cold and Flu Drugs Market Analysis
- 6.1.1 Cough And Cold Remedies
- 6.1.2 Market Analysis by Region (Before COVID-19)
- 6.1.3 Market Analysis by Region (V-shaped)
- 6.1.4 Market Analysis by Region (W-shaped)
- 6.1.5 Market Analysis by Region (U-shaped)
- 6.1.6 Market Analysis by Region (L-shaped)
- 6.2 Analgesics Market Analysis
- 6.2.1Analgesics Are Frequently Used In Combination
- 6.2.2 ACETAMINOPHEN
- 6.2.3 NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)
- 6.2.4 Market Analysis in By Region (Before COVID-19)
- 6.2.5 Market Analysis by Region (V-shaped)
- 6.2.6 Market Analysis by Region (W-shaped)
- 6.2.7 Market Analysis by Region (U-shaped)
- 6.2.8 Market Analysis by Region (L-shaped)
- 6.3 Dermatological Market Analysis
- 6.3.1 Acne treatments are a major revenue earning source for OTC dermal drugs
- 6.3.2 Skincare And Dermatological Drugs
- 6.3.3 Market Analysis by Region (Before COVID-19)
- 6.3.4 Market Analysis by Region (V-shaped)
- 6.3.5 Market Analysis by Region (W-shaped)
- 6.3.6 Market Analysis by Region (U-shaped)
- 6.3.7Market Analysis by Region (L-shaped)
- 6.4 Vitamins and Minerals Market Analysis
- 6.4.1 The Percentage Of Females With Vitamin And Mineral Deficiencies Is Higher Than Males
- 6.4.2 Treatments for Vitamins and Mineral Deficiency
- 6.4.3 Vitamins and Mineral Supplements (VMS)
- 6.4.4 Market Analysis by Region (Before COVID-19)
- 6.4.5 Market Analysis by Region (V-shaped)
- 6.4.6 Market Analysis by Region (W-shaped)
- 6.4.7 Market Analysis by Region (U-shaped)
- 6.4.8 Market Analysis by Region (L-shaped)
- 6.5 Weight Loss/Diet Products Market Analysis
- 6.5.1.The Countries In Latin America Such As Brazil Are Likely To Unfold Remunerative
- Opportunities During The Forecast Period
- 6.5.2 Market Analysis by Region (Before COVID-19)
- 6.5.3 Market Analysis by Region (V-shaped)
- 6.5.4 Market Analysis by Region (W-shaped)
- 6.5.5 Market Analysis by Region (U-shaped)
- 6.5.6 Market Analysis by Region (L-shaped)
- 6.6 Gastrointestinal Drugs Market Analysis
- 6.6.1 Gastrointestinal OTC Remedies Have Been Proven Effective In Primary Care
- 6.6.2 Gastrointestinal Disorder Treatments
- 6.6.3 Market Analysis by Region (Before COVID-19)
- 6.6.4 Market Analysis by Region (V-shaped)
- 6.6.5 Market Analysis by Region (W-shaped)
- 6.6.6 Market Analysis by Region (U-shaped)
- 6.6.7 Market Analysis by Region (L-shaped)
- 6.7 Other Category Market Analysis
- 6.7.1 Oral medical care
- 6.7.2 Eye Care Products
- 6.7.2.1 Use of OTC Products For Ocular Allergy And Dry Eye Are Quietly But Rapidly Growing
- 6.7.3 Market Analysis by Region (Before COVID-19)
- 6.7.4 Market Analysis by Region (V-shaped)
- 6.7.5 Market Analysis by Region (W-shaped)
- 6.7.6 Market Analysis by Region (U-shaped)
- 6.7.7 Market Analysis by Region (L-shaped)
- 7. Market Breakdown by Product Type
- 7.1 Branded Drugs Market Analysis
- 7.1.1 OTC Drug Companies Spending Huge on Marketing To Awareness About Their Brands
- 7.1.2 Market Analysis by Region (Before COVID-19)
- 7.1.3 Market Analysis by Region (V-shaped)
- 7.1.4 Market Analysis by Region (W-shaped)
- 7.1.5 Market Analysis by Region (U-shaped)
- 7.1.6 Market Analysis by Region (L-shaped)
- 7.2 Generic Drugs Market Analysis
- 7.2.1 Generic OTC Are Still in Demand Due to Lower Prices
- 7.2.2 Market Analysis by Region (Before COVID-19)
- 7.2.3 Market Analysis by Region (V-shaped)
- 7.2.4 Market Analysis by Region (W-shaped)
- 7.2.5 Market Analysis by Region (U-shaped)
- 7.2.6 Market Analysis by Region (L-shaped)
- 7.3 Other Product Types Market Analysis
- 7.3.1 Market Analysis by Region (Before COVID-19)
- 7.3.2 Market Analysis by Region (V-shaped)
- 7.3.3 Market Analysis by Region (W-shaped)
- 7.3.4 Market Analysis by Region (U-shaped)
- 7.3.5 Market Analysis by Region (L-shaped)
- 8. Market Breakdown by Dosage Type
- 8.1 Tablets Market Analysis
- 8.1.1 Tablets Segment holds Largest Share in the Global Market
- 8.1.2 Market Analysis by Region (Before COVID-19)
- 8.1.3 Market Analysis by Region (V-shaped)
- 8.1.4 Market Analysis by Region (W-shaped)
- 8.1.5 Market Analysis by Region (U-shaped)
- 8.1.6 Market Analysis by Region (L-shaped)
- 8.2 Hard Capsules Market Analysis
- 8.2.1 Hard Capsules Segment is Expected to Grow at a Decent Growth Rate
- 8.2.2 Market Analysis by Region (Before COVID-19)
- 8.2.3 Market Analysis by Region (V-shaped)
- 8.2.4 Market Analysis by Region (W-shaped)
- 8.2.5 Market Analysis by Region (U-shaped)
- 8.2.6 Market Analysis by Region (L-shaped)
- 8.3 Powders Market Analysis
- 8.3.1 Increasing Demand in the Asia-Pacific Market
- 8.3.2 Market Analysis by Region (Before COVID-19)
- 8.3.3 Market Analysis by Region (V-shaped)
- 8.3.4 Market Analysis by Region (W-shaped)
- 8.3.5 Market Analysis by Region (U-shaped)
- 8.3.6 Market Analysis by Region (L-shaped)
- 8.4 Ointments Market Analysis
- 8.4.1 European Market is Expected to Grow at a Decent Growth Rate
- 8.4.2 Market Analysis by Region (Before COVID-19)
- 8.4.3 Market Analysis by Region (V-shaped)
- 8.4.4 Market Analysis by Region (W-shaped)
- 8.4.5 Market Analysis by Region (U-shaped)
- 8.4.6 Market Analysis by Region (L-shaped)
- 8.5 Soft Capsules Market Analysis
- 8.5.1. North American Consumers Prefer Soft Tablets Over the Hard ones
- 8.5.2 Market Analysis by Region (Before COVID-19)
- 8.5.3 Market Analysis by Region (V-shaped)
- 8.5.4 Market Analysis by Region (W-shaped)
- 8.5.5 Market Analysis by Region (U-shaped)
- 8.5.6 Market Analysis by Region (L-shaped)
- 8.6 Liquids Market Analysis
- 8.6.1 Liquid OTC Drugs are Less Preferred in the Latin America Region
- 8.6.2 Market Analysis by Region (Before COVID-19)
- 8.6.3 Market Analysis by Region (V-shaped)
- 8.6.4 Market Analysis by Region (W-shaped)
- 8.6.5 Market Analysis by Region (U-shaped)
- 8.6.6 Market Analysis by Region (L-shaped)
- 8.7 Other Dosage Forms Market Analysis
- 8.7.1 Market Analysis by Region (Before COVID-19)
- 8.7.2 Market Analysis by Region (V-shaped)
- 8.7.3 Market Analysis by Region (W-shaped)
- 8.7.4 Market Analysis by Region (U-shaped)
- 8.7.5 Market Analysis by Region (L-shaped)
- 9. Market Breakdown by Distribution Channel
- 9.1 Pharmacies/Drugstores Market Analysis
- 9.1.1 This Segment Holds the Largest Share in the Market
- 9.1.2 Market Analysis by Region (Before COVID-19)
- 9.1.3 Market Analysis by Region (V-shaped)
- 9.1.4 Market Analysis by Region (W-shaped)
- 9.1.5 Market Analysis by Region (U-shaped)
- 9.1.6 Market Analysis by Region (L-shaped)
- 9.2 Supermarkets/Hypermarkets Market Analysis
- 9.2.1 Consumers in Metro Cities Prefer to Buy OTC Drugs from Supermarkets/Hypermarkets
- 9.2.2 Market Analysis by Region (Before COVID-19)
- 9.2.3 Market Analysis by Region (V-shaped)
- 9.2.4 Market Analysis by Region (W-shaped)
- 9.2.5 Market Analysis by Region (U-shaped)
- 9.2.6 Market Analysis by Region (L-shaped)
- 9.3 Convenience Stores Market Analysis
- 9.3.1 Trends Shifting Towards Convenience Stores Purchase
- 9.3.2 Market Analysis by Region (Before COVID-19)
- 9.3.3 Market Analysis by Region (V-shaped)
- 9.3.4 Market Analysis by Region (W-shaped)
- 9.3.5 Market Analysis by Region (U-shaped)
- 9.3.6 Market Analysis by Region (L-shaped)
- 9.4 Online Drug Stores Market Analysis
- 9.4.1 Online Drug Stores are a Hot Trend in the Global OTC Market
- 9.4.2 Market Analysis by Region (Before COVID-19)
- 9.4.3 Market Analysis by Region (V-shaped)
- 9.4.4 Market Analysis by Region (W-shaped)
- 9.4.5 Market Analysis by Region (U-shaped)
- 9.4.6 Market Analysis by Region (L-shaped)
- 9.5 Health Food Stores Market Analysis
- 9.5.1. Health Cautious Consumers Prefer to Buy OTC From Health Food Stores
- 9.5.2 Market Analysis by Region (Before COVID-19)
- 9.5.3 Market Analysis by Region (V-shaped)
- 9.5.4 Market Analysis by Region (W-shaped)
- 9.5.5 Market Analysis by Region (U-shaped)
- 9.5.6 Market Analysis by Region (L-shaped)
- 9.6 Other Distribution Channel Market Analysis
- 9.6.1 Market Analysis by Region (Before COVID-19)
- 9.6.2 Market Analysis by Region (V-shaped)
- 9.6.3 Market Analysis by Region (W-shaped)
- 9.6.4 Market Analysis by Region (U-shaped)
- 9.6.5 Market Analysis by Region (L-shaped)
- 10. North America Market Analysis
- 10.1 Market Analysis in Terms of Value
- 10.1.1 Market Analysis in Terms of Value (Before COVID-19)
- 10.1.2 Market Analysis in Terms of Value (V-shaped)
- 10.1.3 Market Analysis in Terms of Value (W-shaped)
- 10.1.4 Market Analysis in Terms of Value (U-shaped)
- 10.1.5 Market Analysis in Terms of Value (L-shaped)
- 10.2 Market Analysis by Country
- 10.2.1 US to Dominate the Market During Forecast Period.
- 10.2.2 Market Analysis by Country (Before COVID-19)
- 10.2.3 Market Analysis by Country (V-shaped)
- 10.2.4 Market Analysis by Country (W-shaped)
- 10.2.5 Market Analysis by Country (U-shaped)
- 10.2.6 Market Analysis by Country (L-shaped)
- 10.3 U.S. Market Analysis
- 10.3.1 Vendor Ecosystem For OTC Drugs In The U.S.
- 10.3.2 Multinational OTC Drug Manufacturers
- 10.3.3 Store Brands
- 10.3.4 FMCG Companies
- 10.3.5 Regulations And Approval Process: The U.S.
- 10.3.6 OTC Drug Review
- 10.3.7 OTC Monograph
- 10.3.8 OTC Drugs Developed Through the NDA Process
- 10.3.9 The U.S. Non-prescription Safe-Use Regulatory Expansion (NSURE) Initiative
- 10.3.10 Market Analysis in Terms of Value (Before COVID-19)
- 10.3.11 Market Analysis in Terms of Value (V-shaped)
- 10.3.12 Market Analysis in Terms of Value (W-shaped)
- 10.3.13 Market Analysis in Terms of Value (U-shaped)
- 10.3.14 Market Analysis in Terms of Value (L-shaped)
- 10.4 Canada Market Analysis
- 10.4.1 Canada is the 10th largest pharmaceutical market in the world and the second largest in North America.
- 10.4.2 Market Analysis in Terms of Value (Before COVID-19)
- 10.4.3 Market Analysis in Terms of Value (V-shaped)
- 10.4.4 Market Analysis in Terms of Value (W-shaped)
- 10.4.5 Market Analysis in Terms of Value (U-shaped)
- 10.4.6 Market Analysis in Terms of Value (L-shaped)
- 10.5 Market Analysis by Product Category
- 10.5.1 Market Analysis by Sub-Type (Before COVID-19)
- 10.5.2 Market Analysis by Sub-Type (V-shaped)
- 10.6 Market Analysis by Product Type
- 10.6.1 Market Analysis by Sub-Type (Before COVID-19)
- 10.6.2 Market Analysis by Sub-Type (V-shaped)
- 10.6.3 Market Analysis by Sub-Type (W-shaped)
- 10.6.4 Market Analysis by Sub-Type (U-shaped)
- 10.6.5 Market Analysis by Sub-Type (L-shaped)
- 10.7 Market Analysis by Dosage Form
- 10.7.1 Market Analysis by Sub-Type (Before COVID-19)
- 10.7.2 Market Analysis by Sub-Type (V-shaped)
- 10.7.3 Market Analysis by Sub-Type (W-shaped)
- 10.7.4 Market Analysis by Sub-Type (U-shaped)
- 10.7.5 Market Analysis by Sub-Type (L-shaped)
- 10.8 Market Analysis by Distribution Channel
- 10.8.1 Market Analysis by Sub-Type (Before COVID-19)
- 10.8.2 Market Analysis by Sub-Type (V-shaped)
- 10.8.3 Market Analysis by Sub-Type (W-shaped)
- 10.8.4 Market Analysis by Sub-Type (U-shaped)
- 10.8.5 Market Analysis by Sub-Type (L-shaped)
- 11. Europe Market Analysis
- 11.1.1 BREXIT Effect On The OTC Drug Market In Europe
- 11.1.2 Regulations And Approval Process In Europe
- 11.1.3 Smart Regulation 2015: Europe As A Single Market
- 11.2 Market Analysis in Terms of Value
- 11.2.1 Market Analysis in Terms of Value (Before COVID-19)
- 11.2.2 Market Analysis in Terms of Value (V-shaped)
- 11.2.3 Market Analysis in Terms of Value (W-shaped)
- 11.2.4 Market Analysis in Terms of Value (U-shaped)
- 11.2.5 Market Analysis in Terms of Value (L-shaped)
- 11.3 Market Analysis by Country
- 11.3.1 UK to Dominate the European Market
- 11.3.2 Market Analysis by Country (Before COVID-19)
- 11.3.3 Market Analysis by Country (V-shaped)
- 11.3.4 Market Analysis by Country (W-shaped)
- 11.3.5 Market Analysis by Country (U-shaped)
- 11.3.6 Market Analysis by Country (L-shaped)
- 11.4 U.K. Market Analysis
- 11.4.1 The U.K. has an established market for OTC drugs and dietary supplements
- 11.4.2 Better Regulation of Over-the-Counter Drugs Initiative (BROMI) U.K.
- 11.4.3 Market Analysis in Terms of Value (Before COVID-19)
- 11.4.4 Market Analysis in Terms of Value (V-shaped)
- 11.4.5 Market Analysis in Terms of Value (W-shaped)
- 11.4.6 Market Analysis in Terms of Value (U-shaped)
- 11.4.7 Market Analysis in Terms of Value (L-shaped)
- 11.5 Germany Market Analysis
- 11.5.1 About 30% of Germany’s population frequently uses OTC drugs and dietary supplements for self-medication.
- 11.5.2 The Regulations and Approval Process in Germany
- 11.5.3 Market Analysis in Terms of Value (Before COVID-19)
- 11.5.4 Market Analysis in Terms of Value (V-shaped)
- 11.5.5 Market Analysis in Terms of Value (W-shaped)
- 11.5.6 Market Analysis in Terms of Value (U-shaped)
- 11.5.7 Market Analysis in Terms of Value (L-shaped)
- 11.6 France Market Analysis
- 11.6.1 France is another leading market with strong potential for growth in OTC drugs and dietary supplements
- 11.6.2 Market Analysis in Terms of Value (Before COVID-19)
- 11.6.3 Market Analysis in Terms of Value (V-shaped)
- 11.6.4 Market Analysis in Terms of Value (W-shaped)
- 11.6.5 Market Analysis in Terms of Value (U-shaped)
- 11.6.6 Market Analysis in Terms of Value (L-shaped)
- 11.7 Italy Market Analysis
- 11.7.1OTC Drugs & Dietary Supplements Market is Expected to Grow at a Decent Rate
- 11.7.2 Market Analysis in Terms of Value (Before COVID-19)
- 11.7.3 Market Analysis in Terms of Value (V-shaped)
- 11.7.4 Market Analysis in Terms of Value (W-shaped)
- 11.7.5 Market Analysis in Terms of Value (U-shaped)
- 11.7.6 Market Analysis in Terms of Value (L-shaped)
- 11.8 Spain Market Analysis
- 11.8.1 OTC products are allowed to be freely priced
- 11.8.2 Market Analysis in Terms of Value (Before COVID-19)
- 11.8.3 Market Analysis in Terms of Value (V-shaped)
- 11.8.4 Market Analysis in Terms of Value (W-shaped)
- 11.8.5 Market Analysis in Terms of Value (U-shaped)
- 11.8.6 Market Analysis in Terms of Value (L-shaped)
- 11.9 Rest of Europe Market Analysis
- 11.9.1 The Russian OTC Drug and Dietary Supplements
- 11.9.2 The Polish OTC Drug and Dietary Supplements
- 11.9.3 Market Analysis in Terms of Value (Before COVID-19)
- 11.9.4 Market Analysis in Terms of Value (V-shaped)
- 11.9.5 Market Analysis in Terms of Value (W-shaped)
- 11.9.6 Market Analysis in Terms of Value (U-shaped)
- 11.9.7 Market Analysis in Terms of Value (L-shaped)
- 11.10 Market Analysis by Product Category
- 11.10.1 Market Analysis by Sub-Type (Before COVID-19)
- 11.10.1 Market Analysis by Sub-Type (V-shaped)
- 11.10.1 Market Analysis by Sub-Type (W-shaped)
- 11.10.1 Market Analysis by Sub-Type (U-shaped)
- 11.10.1 Market Analysis by Sub-Type (L-shaped)
- 11.11 Market Analysis by Product Type
- 11.11.1 Market Analysis by Sub-Type (Before COVID-19)
- 11.11.2 Market Analysis by Sub-Type (V-shaped)
- 11.11.3 Market Analysis by Sub-Type (W-shaped)
- 11.11.4 Market Analysis by Sub-Type (U-shaped)
- 11.11.5 Market Analysis by Sub-Type (L-shaped)
- 11.12 Market Analysis by Dosage Form
- 11.12.1 Market Analysis by Sub-Type (Before COVID-19)
- 11.12.2 Market Analysis by Sub-Type (V-shaped)
- 11.12.3 Market Analysis by Sub-Type (W-shaped)
- 11.12.4 Market Analysis by Sub-Type (U-shaped)
- 11.12.5 Market Analysis by Sub-Type (L-shaped)
- 11.13 Market Analysis by Distribution Channel
- 11.13.1 Market Analysis by Sub-Type (Before COVID-19)
- 11.13.2 Market Analysis by Sub-Type (V-shaped)
- 11.13.3 Market Analysis by Sub-Type (W-shaped)
- 11.13.4 Market Analysis by Sub-Type (U-shaped)
- 11.13.5 Market Analysis by Sub-Type (L-shaped)
- 12. Asia-Pacific Market Analysis
- 12.1 Market Analysis in Terms of Value
- 12.1.1 Market Analysis in Terms of Value (Before COVID-19)
- 12.1.2 Market Analysis in Terms of Value (V-shaped)
- 12.1.3 Market Analysis in Terms of Value (W-shaped)
- 12.1.4 Market Analysis in Terms of Value (U-shaped)
- 12.1.5 Market Analysis in Terms of Value (L-shaped)
- 12.2 Market Analysis by Country
- 12.2.1 China to Maintain its Dominance in the Asia-Pacific Market
- 12.2.2 Market Analysis in By Country (Before COVID-19)
- 12.2.3 Market Analysis by Country (V-shaped)
- 12.2.4 Market Analysis by Country (W-shaped)
- 12.2.5 Market Analysis by Country (U-shaped)
- 12.2.6 Market Analysis by Country (L-shaped)
- 12.3 China Market Analysis
- 12.3.1.Though OTC drug advertising is permissive in China, there are strict regulations for advertisement contents
- 12.3.2 New Amendments in Regulating Drug Advertising in 2015
- 12.3.3 Market Analysis in Terms of Value (Before COVID-19)
- 12.3.4 Market Analysis in Terms of Value (V-shaped)
- 12.3.5 Market Analysis in Terms of Value (W-shaped)
- 12.3.6 Market Analysis in Terms of Value (U-shaped)
- 12.3.7 Market Analysis in Terms of Value (L-shaped)
- 12.4 India Market Analysis
- 12.4.1. New urban upwardly mobile class has increased the use of OTC drugs
- 12.4.2 India: Regulation and Approval Processes
- 12.4.3 Market Analysis in Terms of Value (Before COVID-19)
- 12.4.4 Market Analysis in Terms of Value (V-shaped)
- 12.4.5 Market Analysis in Terms of Value (W-shaped)
- 12.4.6 Market Analysis in Terms of Value (U-shaped)
- 12.4.7 Market Analysis in Terms of Value (L-shaped)
- 12.5 Japan Market Analysis
- 12.5.1 Japan has strict criteria for classifying OTC drugs and adheres to stringent point-of-sales policies
- 12.5.2 The Regulation and Approval Process in Japan
- 12.5.3 Market Analysis in Terms of Value (Before COVID-19)
- 12.5.4 Market Analysis in Terms of Value (V-shaped)
- 12.5.5 Market Analysis in Terms of Value (W-shaped)
- 12.5.6 Market Analysis in Terms of Value (U-shaped)
- 12.5.7 Market Analysis in Terms of Value (L-shaped)
- 12.6 South Korea Market Analysis
- 12.6.1 An increase in self-medication and a growing geriatric population with chronic diseases
- 12.6.2 Market Analysis in Terms of Value (Before COVID-19)
- 12.6.3 Market Analysis in Terms of Value (V-shaped)
- 12.6.4 Market Analysis in Terms of Value (W-shaped)
- 12.6.5 Market Analysis in Terms of Value (U-shaped)
- 12.6.6 Market Analysis in Terms of Value (L-shaped)
- 12.7 Australia Market Analysis
- 12.7.1 OTC drugs can be registered or listed on the Australian Register of Therapeutic Goods (ARTG)
- 12.7.2 Regulation and Approval Process: Australia
- 12.7.3 Joint Australian and New Zealand Phased Implementation Plan 2013
- 12.7.4 N2 Applications (Using OTC Monographs) Version1, September 2013
- 12.7.5 Market Analysis in Terms of Value (Before COVID-19)
- 12.7.6 Market Analysis in Terms of Value (V-shaped)
- 12.7.7 Market Analysis in Terms of Value (W-shaped)
- 12.7.8 Market Analysis in Terms of Value (U-shaped)
- 12.7.9 Market Analysis in Terms of Value (L-shaped)
- 12.8 Rest of Asia-Pacific Market Analysis
- 12.8.1 Market Analysis in Terms of Value (Before COVID-19)
- 12.8.2 Market Analysis in Terms of Value (V-shaped)
- 12.8.3 Market Analysis in Terms of Value (W-shaped)
- 12.8.4 Market Analysis in Terms of Value (U-shaped)
- 12.8.5 Market Analysis in Terms of Value (L-shaped)
- 12.9 Market Analysis by Product Category
- 12.9.1 Market Analysis by Sub-Type (Before COVID-19)
- 12.9.2 Market Analysis by Sub-Type (V-shaped)
- 12.9.3 Market Analysis by Sub-Type (W-shaped)
- 12.9.4 Market Analysis by Sub-Type (U-shaped)
- 12.9.5 Market Analysis by Sub-Type (L-shaped)
- 12.10 Market Analysis by Product Type
- 12.10.1 Market Analysis by Sub-Type (Before COVID-19)
- 12.10.2 Market Analysis by Sub-Type (V-shaped)
- 12.10.3 Market Analysis by Sub-Type (W-shaped)
- 12.10.4 Market Analysis by Sub-Type (U-shaped)
- 12.10.5 Market Analysis by Sub-Type (L-shaped)
- 12.11 Market Analysis by Dosage Form
- 12.11.1 Market Analysis by Sub-Type (Before COVID-19)
- 12.11.2 Market Analysis by Sub-Type (V-shaped)
- 12.11.3 Market Analysis by Sub-Type (W-shaped)
- 12.11.4 Market Analysis by Sub-Type (U-shaped)
- 12.11.5 Market Analysis by Sub-Type (L-shaped)
- 12.12 Market Analysis by Distribution Channel
- 12.12.1 Market Analysis by Sub-Type (Before COVID-19)
- 12.12.2 Market Analysis by Sub-Type (V-shaped)
- 12.12.3 Market Analysis by Sub-Type (W-shaped)
- 12.12.4 Market Analysis by Sub-Type (U-shaped)
- 12.12.5 Market Analysis by Sub-Type (L-shaped)
- 13. Middle East & Africa Market Analysis
- 13.1 Market Analysis in Terms of Value
- 13.1.1 Market Analysis in Terms of Value (Before COVID-19)
- 13.1.2 Market Analysis in Terms of Value (V-shaped)
- 13.1.3 Market Analysis in Terms of Value (W-shaped)
- 13.1.4 Market Analysis in Terms of Value (U-shaped)
- 13.1.5 Market Analysis in Terms of Value (L-shaped)
- 13.2 Market Analysis by Country
- 13.2.1 South America to Lead the MEA Market
- 13.2.2 Market Analysis by Country (Before COVID-19)
- 13.2.3 Market Analysis by Country (V-shaped)
- 13.2.4 Market Analysis by Country (W-shaped)
- 13.2.5 Market Analysis by Country (U-shaped)
- 13.2.6 Market Analysis by Country (L-shaped)
- 13.3 South Africa Market Analysis
- 13.3.1 The OTC derivatives market plays an important role in domestic financial markets and the economy
- 13.3.2 Market Analysis in Terms of Value (Before COVID-19)
- 13.3.3 Market Analysis in Terms of Value (V-shaped)
- 13.3.4 Market Analysis in Terms of Value (W-shaped)
- 13.3.5 Market Analysis in Terms of Value (U-shaped)
- 13.3.6 Market Analysis in Terms of Value (L-shaped)
- 13.4 Turkey Market Analysis
- 13.4.1 There is currently a lack of OTC regulations and classifications in Turkey
- 13.4.2 Market Analysis in Terms of Value (Before COVID-19)
- 13.4.3 Market Analysis in Terms of Value (V-shaped)
- 13.4.4 Market Analysis in Terms of Value (W-shaped)
- 13.4.5 Market Analysis in Terms of Value (U-shaped)
- 13.4.6 Market Analysis in Terms of Value (L-shaped)
- 13.5 Saudi Arabia Market Analysis
- 13.5.1 Saudi Arabia OTC Drugs market is dominated by branded drugs
- 13.5.2 Market Analysis in Terms of Value (Before COVID-19)
- 13.5.3 Market Analysis in Terms of Value (V-shaped)
- 13.5.4 Market Analysis in Terms of Value (W-shaped)
- 13.5.5 Market Analysis in Terms of Value (U-shaped)
- 13.5.6 Market Analysis in Terms of Value (L-shaped)
- 13.6 UAE Market Analysis
- 13.6.1 Increasing Incomes And Awareness Lead To An Increase In Personal Care.
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook